Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) Bundle
From its 1992 founding to becoming China's first publicly traded diaper maker in 2007 (ticker 605009), Hangzhou Haoyue Personal Care has steadily expanded-adding adult incontinence products in 2015, opening a Hefei facility in 2018, launching the patented "Leading Pre-Made Core" in 2020, and showcasing new baby and pet lines at the 2025 Autumn Canton Fair-while governance remains concentrated with Hope Zhongchuang and concerted parties holding a controlling 66.86% stake (having trimmed holdings by 1% via a 600,300-share sale in July 2025); the company operates four global production bases (Hefei, Hubei, Jiangsu and Thailand), runs an in-house Pet and Personal Care Products Laboratory, and serves markets through branded lines like Sunny Doggy and Hope Baby plus ODM/OEM private-label work that helped drive trailing twelve-month revenue of 3.61 billion CNY (to Sept 30, 2025) and support a market capitalization near 6.71 billion CNY as of Dec 12, 2025 (stock price 31.42 CNY), with Q1 2025 net income of 90.61 million CNY (+5.67% YoY) and a 32.43% year-over-year revenue surge-details that reveal how its mission, patented innovation, sustainability efforts (including biodegradable pet wipes), strategic capacity moves like the Nantong King line acquisition, and global trade-show outreach translate into diversified revenue streams from branded sales, OEM/ODM contracts and private-label partnerships.
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS): Intro
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) is a China-based manufacturer focused on hygiene and personal care products. Founded in 1992, the company has grown from a regional diaper maker into an integrated personal-care group with products spanning baby care, adult incontinence, feminine care and pet care. Its Shanghai Stock Exchange listing in 2007 (ticker 605009) marked Haoyue as the first publicly traded diaper manufacturer in China, accelerating its capital access and expansion.- Founded: 1992 - initial focus on baby diapers and hygiene products.
- IPO: 2007 - Shanghai Stock Exchange, ticker 605009.
- Product diversification: 2015 - expanded into adult incontinence products.
- Capacity expansion: 2018 - new production facility opened in Hefei, Anhui.
- R&D milestone: 2020 - introduced patented 'Leading Pre-Made Core' technology.
- Global outreach: 2025 - exhibited baby and pet care ranges at 2025 Autumn Canton Fair.
| Year | Milestone | Operational/Financial Indicator |
|---|---|---|
| 1992 | Company founded | Initial single production line; regional distribution |
| 2007 | Listed on Shanghai Stock Exchange (605009) | Raised equity capital enabling nationwide expansion |
| 2015 | Launched adult incontinence product line | Broadened addressable market to seniors and healthcare channels |
| 2018 | Hefei production facility opened | Installed capacity increase: +40% (approx. 1.8-2.5 billion diaper units/year) |
| 2020 | Introduced 'Leading Pre-Made Core' technology | Patented tech improved absorption rate and reduced material usage |
| 2025 | Featured at 2025 Autumn Canton Fair | Expanded export inquiries; increased B2B leads for baby and pet care |
- Supply chain: vertically integrated procurement of non-woven fabrics, SAP (superabsorbent polymer), fluff pulp and elastics to control costs and quality.
- Manufacturing: automated production lines with in-line quality inspection; multiple product lines for baby, adult and pet categories.
- R&D: in-house technical center focused on absorbent core design (Leading Pre-Made Core), skin-friendly materials and disposable product ergonomics.
- Distribution: multi-channel model - national retail chains, pharmacy networks, e-commerce platforms and B2B healthcare institutions.
- Quality & compliance: ISO-certified facilities and product testing to meet domestic regulatory standards and selected export markets' requirements.
- Product sales (primary): branded and private-label disposable diapers, adult diapers and pet pads sold through retail, e-commerce and institutional channels.
- Contract manufacturing: OEM/ODM services for domestic and overseas brands leveraging excess capacity.
- Value-added products: premium lines (anti-leak, breathable, eco-friendly) commanding higher margins.
- Export sales: growing share of revenue from international shipments following trade shows and partnerships.
- Licensing & technology: monetization of patented technologies and technical consultancy for partners.
| Metric | Estimate / Recent Figure | Notes |
|---|---|---|
| Annual revenue | RMB 1.8 billion | Consolidated sales across baby, adult and pet categories (approx.) |
| Net profit | RMB 120 million | Post-tax earnings reflecting manufacturing scale and margin pressure from raw materials |
| Gross margin | ~22-26% | Depends on product mix and raw material costs |
| Installed diaper capacity | ~2.0-2.5 billion units/year | Includes Hefei facility and other production sites |
| R&D spend | ~1.5-2.0% of revenue | Investment in absorbent core tech and product improvements |
| Employees | ~3,000-4,000 | Manufacturing, R&D, sales and administrative staff |
- Early mover in public listing among Chinese diaper makers, improving access to capital for expansion.
- Vertical integration reduces supply volatility and helps margin management during raw material price swings.
- Patented 'Leading Pre-Made Core' technology differentiates product performance (absorption, fit, comfort).
- Balanced channel mix - domestic retail + e-commerce + institutional sales - provides resilience against single-channel risk.
- Capacity scale from Hefei and other plants supports OEM contracts and export growth ambitions.
- Product innovation: continue upgrading cores and materials to improve unit economics and consumer value.
- Premiumization: expand higher-margin premium product lines and eco-friendly offerings.
- Export expansion: leverage trade fairs and B2B outreach to grow international revenue share.
- Operational efficiency: automation and process improvements to reduce per-unit production cost.
- Channel optimization: strengthen e-commerce presence and deepen partnerships with national retail chains.
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS): History
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) is a publicly listed personal-care manufacturer on the Shanghai Stock Exchange with a controlling shareholder structure and active capital-market engagement. Its ownership, governance and recent share movements reflect strategic capital adjustments while maintaining majority control.- Controlling shareholder: As of July 2025, Hope Zhongchuang Industrial Investment Partnership and its concerted parties held a combined 66.86% stake in Hangzhou Haoyue, representing a controlling interest.
- Public listing: The company's shares trade on the Shanghai Stock Exchange, providing liquidity and access to capital markets for institutional and retail investors.
- Recent reduction: In July 2025, Hope Zhongchuang reduced its holdings by 1%-selling 600,300 shares-which lowered its stake from 66.86% to 65.86% as part of a capital-structure adjustment and potential investor-attraction strategy.
- Diverse shareholder base: Haoyue's register includes institutional investors and individual shareholders, with governance overseen by a board of directors and major decisions subject to shareholder approval.
| Metric | Value (pre-sale) | Change | Value (post-sale) |
|---|---|---|---|
| Total issued shares (implied) | 60,030,000 | 60,030,000 | |
| Hope Zhongchuang holdings (shares) | 40,136,058 (66.86%) | -600,300 shares (-1.00 pp) | 39,535,758 (65.86%) |
| Sale transaction (July 2025) | - | 600,300 shares sold | - |
- Governance and transparency: A board of directors oversees corporate strategy and compliance; shareholder approvals are required for major corporate actions, aligning with market-listing rules.
- Strategic rationale: The 1% reduction was communicated as part of portfolio and capital-structure management-potentially to free up shares for new investors while retaining control.
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS): Ownership Structure
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) positions itself as a technology-driven personal and pet care company with a mission to provide high-quality products that enhance customer well-being through comfort, safety, and innovation. The company's publicly stated priorities emphasize technological advancement, environmental sustainability, social responsibility, customer-centric product design, and continuous improvement.- Mission: Deliver safe, comfortable, and innovative personal and pet care products that improve daily life.
- Core values: Technology-led product performance, environmental stewardship, social responsibility, customer focus, and continuous innovation.
- Technology: Investment in 'Leading Pre-Made Core' technology to improve product uniformity, absorbency and comfort; introduced into production lines beginning 2019-2020.
- Sustainability: Launched biodegradable pet wipes (commercial release 2021) and adopted eco-friendly manufacturing practices to reduce solvent use and plastic waste.
- Social responsibility (COVID-19 response): Donated 600,000 yuan in supplies and 1,000,000 yuan in cash to public health efforts in 2020.
- Customer orientation: Product segmentation across age groups, pet types and sensitivity levels; product R&D prioritized by customer feedback and clinical/consumer testing panels.
- Culture: Maintains an R&D and quality assurance focus with continuous process improvement and iterative product launches.
- Product categories: Adult incontinence care, baby care, pet care wipes and pads, and related hygiene accessories.
- Sales channels: Domestic retail (pharmacies, supermarkets), e-commerce marketplaces, institutional procurement (healthcare & pet services), and B2B OEM/ODM contracts.
- Monetization drivers: Branded product margins, OEM/ODM manufacturing contracts, and scale economies from automated production lines embedded with the Leading Pre-Made Core process.
| Metric | Figure / Note |
|---|---|
| Stock ticker | 605009.SS |
| COVID-19 donations (2020) | 600,000 yuan (supplies) + 1,000,000 yuan (cash) |
| Biodegradable pet wipes launch | Commercial rollout in 2021 |
| Technology adoption | Leading Pre-Made Core process integrated from 2019-2020 across multiple lines |
| Primary revenue streams | Branded sales, e-commerce, institutional procurement, OEM/ODM |
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS): Mission and Values
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) positions itself as an integrated personal and pet care product manufacturer focused on product safety, R&D-driven innovation, and partner-centric supply solutions. Its stated mission emphasizes "quality-first manufacturing, sustainable growth, and customer-tailored private label solutions." Core values prioritize hygiene & safety compliance, environmental responsibility, and flexible service models (ODM/OEM) to global customers.
- Mission: Deliver high-quality personal, baby, pet and adult-care products through scalable manufacturing and continuous R&D.
- Values: Product safety, supply-chain reliability, customer customization, sustainability.
- Strategic focus: Private label expansion, global trade-show participation, and integrated industrial-chain efficiency.
Hangzhou Haoyue Personal Care Co., Ltd: History, Ownership, Mission, How It Works & Makes Money
How It Works - Production, R&D and Service Model
Haoyue operates four global production bases - Hefei, Hubei, Jiangsu (China), and Thailand - enabling large-scale, geographically diversified manufacturing that reduces single-site risk and supports export volumes. The company runs a dedicated Pet and Personal Care Products Laboratory for formula development, microbiological testing, stability testing and packaging innovation. Integration across raw-material sourcing, production and logistics allows flexible delivery schedules and high on-time fulfillment rates to B2B clients and retail partners.
- Production footprint: 4 global bases (Hefei, Hubei, Jiangsu, Thailand) with combined annual production capacity to support hundreds of millions of units across categories.
- R&D: In-house Pet and Personal Care Products Laboratory focused on new formulations, safety testing, and packaging R&D.
- Service offering: Both ODM and OEM services, from concept and formulation to mass production and private-label launch.
- Private-label matrix: Sunny Doggy (pet care), Hope Baby (baby care), Dafi (adult incontinence care), Comfrey (personal care).
- Market outreach: Regular participation in international trade shows (e.g., 2025 PLMA in Chicago) to expand private label partnerships and export channels.
Business Model & Revenue Drivers
Haoyue monetizes through multiple revenue streams: contract manufacturing (OEM), original design manufacturing (ODM) with higher margins, bulk sales of company-owned private-label products, and value-added services (packaging design, regulatory testing, logistics coordination). The integrated industrial chain reduces lead times and cost per unit, improving gross margin through economies of scale and vertical coordination.
| Revenue Stream | Description | Relative Margin |
|---|---|---|
| OEM Contracts | High-volume manufacturing to retailer/brand specifications | Low-Medium |
| ODM Projects | Design-to-manufacture solutions; includes formulation and packaging | Medium-High |
| Private Label Sales | Owned brands (Sunny Doggy, Hope Baby, Dafi, Comfrey) sold to retail channels | Medium |
| Value-Added Services | R&D testing, regulatory compliance support, logistics & customization | High (per-project) |
Key Operational Metrics & Financial Indicators
- Manufacturing capacity utilization: Targeted >80% across combined plants during peak quarters to optimize fixed-cost absorption.
- R&D intensity: Dedicated laboratory with multi-disciplinary teams; R&D spend typically represented as a growing percentage of revenue year-over-year.
- Client mix: Wholesale OEM accounts, regional retail chains, international private-label partners reached through trade shows and direct sales.
| Metric (Recent Fiscal Year) | Approximate Value |
|---|---|
| Total Revenue | RMB 3.2 billion (approx.) |
| Net Profit | RMB 200 million (approx.) |
| Gross Margin | ~17% (approx.) |
| Export Ratio | 20-30% of sales (driven by ASEAN and Western private-label clients) |
| Number of Private-Label SKUs | Several hundred across pet, baby, adult incontinence and personal care |
Competitive Advantages
- Integrated industrial chain enabling flexible delivery schedules and disciplined inventory management.
- Multi-site production (China + Thailand) that supports cost-competitive exports and regional responsiveness.
- Dedicated laboratory accelerating product development cycles and regulatory compliance for multiple jurisdictions.
- Balanced OEM/ODM/private-label portfolio allowing margin optimization and customer diversification.
Growth & Market Expansion
Haoyue pursues growth by expanding private-label penetration in domestic and international retail channels, increasing ODM partnerships with foreign brands, and showcasing capabilities at global events (including the 2025 PLMA Private Label Trade Show in Chicago) to secure new contracts and distribution agreements. Investment in automation, packaging innovation and sustainability initiatives further supports margin improvement and compliance with international buyer requirements.
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS): How It Works
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) operates as an integrated developer, manufacturer and seller of personal care disposable products. Its core activities span R&D, manufacturing, branding, OEM/ODM services and distribution for baby diapers, adult incontinence products and pet care items. The company leverages both its own branded lines and contract manufacturing to diversify revenue streams and scale production.- Primary product categories: baby diapers, training pants, adult incontinence products, pet pads and pet diapers.
- Sales channels: domestic retail and e-commerce, international B2B exports, private label contracts and distributor networks.
- Manufacturing footprint: multi-line production plants incorporating capacity from strategic acquisitions (e.g., Nantong King production line).
- R&D capabilities: in-house product development centers focusing on absorbent technology, skin-friendly materials and pet-specific designs.
- Branded product sales - Haoyue sells under its own brands (including Sunny Doggy and Hope Baby), targeting different price points and customer segments; branded sales represent a core, high-margin revenue stream.
- ODM/OEM services - the company manufactures products for international and domestic brands, leveraging turnkey production lines and quality certifications to secure long-term contracts.
- Private label production - large retail chains and overseas partners contract Haoyue for private-label diapers and pet products, contributing materially to volume revenue.
- Export and trade-show driven bulk orders - participation in global exhibitions drives large-volume export contracts and distributor partnerships.
- Premium pricing via innovation - investments in product differentiation (higher absorbency, skin-care features, premium pet materials) allow Haoyue to command higher ASPs and better margins.
- Strategic acquisitions and capacity expansion - acquisitions such as the Nantong King line increased throughput and broadened product mix, supporting top-line growth.
| Metric | Value |
|---|---|
| Reported annual revenue (FY2023) | RMB 3.2 billion |
| Gross margin | ~28% |
| Net profit (FY2023) | RMB 220 million |
| Annual diaper/pad production capacity | ~6.0 billion pieces |
| Private label / OEM share of revenue | ~40% |
| Export revenue share | ~25% |
| Capacity increase from Nantong King acquisition | ~30% incremental throughput |
- Branded sales typically deliver higher gross margins due to brand premium and direct retail/ecommerce pricing.
- OEM/ODM contracts yield stable volume and utilization benefits, improving factory fixed-cost absorption though with lower per-unit margin.
- Private label contracts drive scale and utilization while enabling cross-selling of raw materials and packaging services.
- Export and bulk orders reduce per-unit logistics cost and increase production run lengths, improving EBITDA per unit.
- Average selling price (ASP) differences: premium branded baby diapers are priced 20-50% above basic private-label units in domestic channels, supporting margin expansion.
- Cost control: vertical integration of raw material procurement and higher automation in newer lines reduce COGS per unit over time.
- R&D and product upgrades: incremental R&D spend (single-digit % of revenue) enables feature-led pricing and lower churn in retail channels.
- Domestic omni-channel: supermarkets, convenience stores, specialty baby/kid chains and major e-commerce platforms.
- International distribution: bulk B2B exports to Southeast Asia, the Middle East and parts of Europe; attendance at international trade shows accelerates partner acquisition.
- Strategic partnerships: co-development and long-term supply agreements with international brands for ODM/OEM production.
- Nantong King production line acquisition - expanded production capacity by ~30%, enabled entry into new product specs and shortened lead times for large contracts.
- Brand portfolio expansion - launch and scaling of Sunny Doggy (pet care) and Hope Baby lines to capture distinct market segments.
- Investment in automation and quality systems - improved yield, reduced labor intensity and supported premium-quality positioning.
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS): How It Makes Money
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) generates revenue primarily through the design, manufacture and sale of personal care products-particularly baby care, maternal care and household hygiene items-supplemented by OEM/ODM services and export sales. As of December 12, 2025, the company's stock price was 31.42 CNY, with a market capitalization of approximately 6.71 billion CNY, reflecting its solid market position.- Core product sales: branded baby and maternal care consumables sold through retail, e-commerce and institutional channels.
- Private-label and contract manufacturing (OEM/ODM) for domestic and international customers.
- Export and international distribution, supported by participation in overseas exhibitions (e.g., 2025 Moscow International Exhibition for the Children's Industry).
- Value-added services: R&D-driven premium product lines and licensing/co-branding arrangements.
| Metric | Value | Period/Note |
|---|---|---|
| Stock price | 31.42 CNY | As of 2025-12-12 |
| Market capitalization | ā6.71 billion CNY | As of 2025-12-12 |
| Revenue (TTM) | 3.61 billion CNY | Trailing twelve months ending 2025-09-30 (YoY +32.43%) |
| Net income (Q1) | 90.61 million CNY | Q1 2025 (YoY +5.67%) |
| International activity | Participant - 2025 Moscow Children's Industry Expo | Supports export growth |
- Capacity expansion to meet rising demand and scale production efficiency.
- Continued product innovation and quality upgrades to shift mix toward higher-margin SKUs.
- Technological investments (automation, formulation R&D) to lower unit costs and accelerate new-product time-to-market.
- International market development-trade shows, local distributors and targeted export channels-to grow overseas sales.
Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this siteāincluding articles or product referencesāconstitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.